A recent study showed the salutary effect of ASXL1, RUNX1, and EZH2 mutations on the risk of arterial thrombosis in ET patients and the prognostic interaction between extreme thrombocytosis and CALR mutation in influencing the incidence of arterial events at the time of diagnosis [121]. Here, ASXL1 is linked to essential thrombocythemia.